Extending survival of cancer patients with elevated levels of EGF or TGF-alpha

Details for Australian Patent Application No. 2007259171 (hide)

Owner GENENTECH, INC F. Hoffmann-La Roche AG

Inventors Strauss, Andreas; Moecks, Joachim; Rabbee, Nusrat; Amler, Lukas C.

Agent Griffith Hack

Pub. Number AU-A-2007259171

PCT Pub. Number WO2007/145862

Priority 60/811,234 05.06.06 US

Filing date 31 May 2007

Wipo publication date 21 December 2007

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/145862 Priority application(s): WO2007/145862

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007259199-Hanging or storage means attachable to a sink

2007259144-Benzamide derivatives as modulators of 11beta-HSD1 for treating diabetes and obesity